Tenax Therapeutics
TENX
21 hedge funds and large institutions have $35.8M invested in Tenax Therapeutics in 2015 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.
500% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 1
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
31% more funds holding
Funds holding: 16 → 21 (+5)
12% less capital invested
Capital invested by funds: $40.6M → $35.8M (-$4.77M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CA
Commerzbank Aktiengesellschaft
Frankfurt,
Germany
|
+$2.63M |
| 2 |
AC
Armistice Capital
New York
|
+$343K |
| 3 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$343K |
| 4 |
BBA
Baker Bros. Advisors
New York
|
+$229K |
| 5 |
BCM
Bourgeon Capital Management
Darien,
Connecticut
|
+$114K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$343K |
| 2 |
Creative Planning
Overland Park,
Kansas
|
-$162K |
| 3 |
FNYS
First New York Securities
New York
|
-$29.5K |
| 4 |
FMA
FNY Managed Accounts
New York
|
-$11.1K |
| 5 |
Citigroup
New York
|
-$7K |
TENX Hedge Fund Activity: Q3 2015 in Review
21 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Tenax Therapeutics (TENX) for Q3 2015, worth a combined $35.8M — down 12% from $40.6M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new TENX positions and 1 closed out — a net gain of 5 holders — while 2 added to existing stakes and 1 trimmed.
The largest buyer was Commerzbank Aktiengesellschaft, opening a new position worth an estimated $2.63M. The largest seller was Sabby Management, cutting an estimated $343K.
- 21 institutional investors held Tenax Therapeutics (TENX) as of Q3 2015, up from 16 in Q2 2015.
- Funds reported $35.8M of Tenax Therapeutics stock for Q3 2015, down 12% quarter-over-quarter.
- 6 funds opened new Tenax Therapeutics positions in Q3 2015 and 1 closed out, a net change of +5 holders.
- The largest Tenax Therapeutics buyer in Q3 2015 was Commerzbank Aktiengesellschaft, an estimated $2.63M added.
- The largest Tenax Therapeutics seller in Q3 2015 was Sabby Management, an estimated $343K sold.
Based on aggregated 13F filings for Q3 2015.